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Background
HIV-infected patients have a higher risk of developing
hematological adverse drug reactions (ADRs) than the
general population and have a significant impact on
patients’ current and future care options. The study was
to determine the causality, the incidence rate, severity
pattern of occurrence of hematological ADRs associated
with highly active antiretroviral therapy in HIV positive
patients.
Methods
Prospective observational study conducted at medicine
department, Kasturba Hospital over a period of 6
months. Enrolled HIV positive patients were intensively
monitored for hematological ADRs associated with fixed
dose of highly active antiretroviral therapy. Causality of
adverse drug reactions was assessed by using WHO
probability scale and also with Naranjo’s algorithm.
Results
Monitoring of 70 HIV positive patients (58 males and 12
females) with fixed dose drug combinations of antiretro-
viral therapy by active pharmacovigilance identified 47.3%
cases of anemia, 15.7% cases of leucopenia, 21% cases of
pancytopenia, 5.2% of eosinophilia, 10.5% cases of bicyto-
penia. The incidence rate of hematological adverse drug
reactions was 37.9% and most of the reported ADR’s were
definitely predictable and preventable. Fifty percent of
these ADR’s were lead to hospitalization and seventy per-
cent of these ADR’s were of moderate in severity. Hemato-
logical ADRs were highest with Zidovudine + Lamivudine
+ Nevirapine (68.4%) and Zidovudine + Lamivudine + Efa-
virenz (31.57%) combinations.
Conclusion
With the increasing access to use of highly active antire-
troviral in India, clinician must focus for routine moni-
toring of hematological investigations for early detection
and prevention of adverse effects associated with highly
active antiretroviral therapy.
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